These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33857801)

  • 21. CCR10+ epithelial cells from idiopathic pulmonary fibrosis lungs drive remodeling.
    Habiel DM; Espindola MS; Jones IC; Coelho AL; Stripp B; Hogaboam CM
    JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Danger-associated molecular patterns and danger signals in idiopathic pulmonary fibrosis.
    Ellson CD; Dunmore R; Hogaboam CM; Sleeman MA; Murray LA
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):163-8. PubMed ID: 24749648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.
    Gabasa M; Royo D; Molina-Molina M; Roca-Ferrer J; Pujols L; Picado C; Xaubet A; Pereda J
    PLoS One; 2013; 8(6):e65445. PubMed ID: 23755232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury.
    Kass DJ; Yu G; Loh KS; Savir A; Borczuk A; Kahloon R; Juan-Guardela B; Deiuliis G; Tedrow J; Choi J; Richards T; Kaminski N; Greenberg SM
    Am J Pathol; 2012 May; 180(5):1963-78. PubMed ID: 22429962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis.
    Morse C; Tabib T; Sembrat J; Buschur KL; Bittar HT; Valenzi E; Jiang Y; Kass DJ; Gibson K; Chen W; Mora A; Benos PV; Rojas M; Lafyatis R
    Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31221805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Epithelial Damage in the Pulmonary Immune Response.
    Burgoyne RA; Fisher AJ; Borthwick LA
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
    Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations.
    Papiris SA; Tomos IP; Karakatsani A; Spathis A; Korbila I; Analitis A; Kolilekas L; Kagouridis K; Loukides S; Karakitsos P; Manali ED
    Cytokine; 2018 Feb; 102():168-172. PubMed ID: 28847533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.
    Hewlett JC; Kropski JA; Blackwell TS
    Matrix Biol; 2018 Oct; 71-72():112-127. PubMed ID: 29625182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis.
    Vittal R; Mickler EA; Fisher AJ; Zhang C; Rothhaar K; Gu H; Brown KM; Emtiazjoo A; Lott JM; Frye SB; Smith GN; Sandusky GE; Cummings OW; Wilkes DS
    PLoS One; 2013; 8(10):e76451. PubMed ID: 24204629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.
    Williamson JD; Sadofsky LR; Hart SP
    Exp Lung Res; 2015 Mar; 41(2):57-73. PubMed ID: 25514507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IPF: new insight on pathogenesis and treatment.
    Harari S; Caminati A
    Allergy; 2010 May; 65(5):537-53. PubMed ID: 20121758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Epithelial-Immune Crosstalk in Pulmonary Fibrosis.
    Planté-Bordeneuve T; Pilette C; Froidure A
    Front Immunol; 2021; 12():631235. PubMed ID: 34093523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endotype-phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease.
    Hoffmann-Vold AM; Weigt SS; Saggar R; Palchevskiy V; Volkmann ER; Liang LL; Ross D; Ardehali A; Lynch JP; Belperio JA
    EBioMedicine; 2019 Dec; 50():379-386. PubMed ID: 31732480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis.
    Tanjore H; Blackwell TS; Lawson WE
    Am J Physiol Lung Cell Mol Physiol; 2012 Apr; 302(8):L721-9. PubMed ID: 22287606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Right place, right time: the evolving role of herpesvirus infection as a "second hit" in idiopathic pulmonary fibrosis.
    Kropski JA; Lawson WE; Blackwell TS
    Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(5):L441-4. PubMed ID: 22180659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory pathways are upregulated in the nasal epithelium in patients with idiopathic pulmonary fibrosis.
    Sala MA; Balderas-Martínez YI; Buendía-Roldan I; Abdala-Valencia H; Nam K; Jain M; Bhorade S; Bharat A; Reyfman PA; Ridge KM; Pardo A; Sznajder JI; Budinger GRS; Misharin AV; Selman M
    Respir Res; 2018 Nov; 19(1):233. PubMed ID: 30477498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pathogenesis of idiopathic pulmonary fibrosis.
    Coward WR; Saini G; Jenkins G
    Ther Adv Respir Dis; 2010 Dec; 4(6):367-88. PubMed ID: 20952439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.
    Bamberg A; Redente EF; Groshong SD; Tuder RM; Cool CD; Keith RC; Edelman BL; Black BP; Cosgrove GP; Wynes MW; Curran-Everett D; De Langhe S; Ortiz LA; Thorburn A; Riches DWH
    Am J Respir Crit Care Med; 2018 Oct; 198(7):914-927. PubMed ID: 29727583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.